Article |

D2 Dopamine Receptor Occupancy: A Crossover Comparison of Risperidone With Clozapine Therapy in Schizophrenic Patients

Tung-Ping Su, MD; Anil K. Malhotra, MD; Kayleen Hadd, RN, MSN; Alan Breier, MD; David Pickar, MD
Arch Gen Psychiatry. 1997;54(10):972-973. doi:10.1001/archpsyc.1997.01830220102017.
Text Size: A A A
Published online

The atypical antipsychotic agents, clozapine and risperidone, have a similar pharmacological profile of D2 dopamine receptor affinity, α2, and serotonin2 antagonism.1 Despite this similarity, the clinical profile of these 2 drugs are quite different. For instance, risperidone produces dose-dependent extrapyramidal side effects, whereas clozapine does not.2 Moreover, there may be differences in the antipsychotic efficacy of these 2 drugs n treatment-resistant patients. One possibility for this difference in clinical profile is that these drugs produce different levels of D2 receptor occupancy. Previous estimates of D2 receptor occupancy of these atypical agents have examined different individuals and do not account for interindividual variation.3, 4 We are, therefore, conducting a double-blind, randomized, crossover sodium iodide I123-benzamide—single photon emission computed tomographic study with schizophrenic patients treated with fixed doses of clozapine and risperidone to investigate the degree of D2 receptor occupancy by these drugs.

To date, we


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.